ir.acorda.comAcorda Therapeutics Inc - Investors
ir.acorda.com Profile
ir.acorda.com
Maindomain:acorda.com
Title:Acorda Therapeutics Inc - Investors
Description：Toggle navigation menu Home About Acorda Company Leadership Management Team Board of Directors Partnering With Acorda Grant Program Scientific Award Compliance Acorda Compliance Biotie EFPIA Discolsur
Discover ir.acorda.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
ir.acorda.com Information
| Website / Domain: | ir.acorda.com |
| HomePage size: | 120.956 KB |
| Page Load Time: | 0.151955 Seconds |
| Website IP Address: | 162.159.129.11 |
| Isp Server: | CloudFlare Inc. |
ir.acorda.com Ip Information
| Ip Country: | United States |
| City Name: | Los Angeles |
| Latitude: | 34.052230834961 |
| Longitude: | -118.24368286133 |
ir.acorda.com Keywords accounting
| Keyword | Count |
|---|
ir.acorda.com Httpheader
| Date: Sun, 25 Oct 2020 09:53:49 GMT |
| Content-Type: text/html; charset=utf-8 |
| Content-Length: 27910 |
| Connection: keep-alive |
| CF-Ray: 5e7b0d7a085f0293-SJC |
| Accept-Ranges: bytes |
| Cache-Control: public, max-age=10, stale-if-error=86400, stale-while-revalidate=86400 |
| Content-Encoding: gzip |
| ETag: a493144ed7e57b894f951e80c87d2155 |
| Vary: Accept-Encoding |
| CF-Cache-Status: REVALIDATED |
| cf-request-id: 0600c6c0410000029374837000000001 |
| Expect-CT: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" |
| X-Content-Type-Options: nosniff |
| X-XSS-Protection: 0 |
| Server: cloudflare |
ir.acorda.com Meta Info
| content="text/html; charset=utf-8" http-equiv="Content-type"/ |
| content="RevealTrans(Duration=0,Transition=0)" http-equiv="Page-Enter"/ |
| content="IE=edge,chrome=1" http-equiv="X-UA-Compatible"/ |
| content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=0" name="viewport"/ |
| content="r_dXeRxWCftg_WJtidbh4G5MMEskzGT3hRuS-DKTles" name="google-site-verification"/ |
162.159.129.11 Domains
| Domain | WebSite Title |
|---|
ir.acorda.com Similar Website
| Domain | WebSite Title |
|---|---|
| Acorda Therapeutics Inc - Investors | |
| Acorda Therapeutics Grant Application Portal | |
| Acorda Therapeutics Biotechnology Company | MS and Spinal Cord Injury Treatments | |
| Investors | PTC Therapeutics, Inc. | |
| INVESTORS | Regulus Therapeutics Inc. | |
| Investors | Flexion Therapeutics, Inc. | |
| Investors | Horizon Therapeutics plc | |
| Connected Investors | Connect With Real Estate Investors | |
| Connected Investors | Connect With Real Estate Investors | |
| Allianz Global Investors Individual Investors | |
| Allianz Global Investors | Individual Investors | |
| Investors | Marathon Oil Corporation - Investors | |
| Allianz Global Investors | Individual Investors | |
| Allianz Global Investors | Individual Investors | |
| Polaris Inc. - Investors - Investors Home |
ir.acorda.com Traffic Sources Chart
ir.acorda.com Alexa Rank History Chart
ir.acorda.com Html To Plain Text
Toggle navigation menu Home About Acorda Company Leadership Management Team Board of Directors Partnering With Acorda Grant Program Scientific Award Compliance Acorda Compliance Biotie EFPIA Discolsures Message From BIO Diversity and Inclusion Contact Us For Patients Focus On Therapies In the Community Resources Policy on Access to Unapproved Medicines Products & Research Pipeline ARCUS® Technology Products AMPYRA® (dalfampridine) INBRIJA™ (levodopa inhalation powder) Clinical Trials Terms and Conditions (Product Purchases) Investors Corporate Governance Stock Information Investor Events Investor News Financial Information Quarterly Updates Annual Reports SEC Filings Analysts Investor Resources Investor Kit E-mail Alerts FAQs IR Contact News & Events In the News Awards Press Releases Social Media Careers Working at Acorda Our Employees Benefits Job Openings Application Investors Our Mission Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders. LEARN MORE -- Home About Acorda Company Leadership Management Team Board of Directors Partnering With Acorda Grant Program Scientific Award Compliance Acorda Compliance Biotie EFPIA Discolsures Message From BIO Diversity and Inclusion Contact Us For Patients Focus On Therapies In the Community Resources Policy on Access to Unapproved Medicines Products & Research Pipeline ARCUS® Technology Products AMPYRA® (dalfampridine) INBRIJA™ (levodopa inhalation powder) Clinical Trials Terms and Conditions (Product Purchases) Investors Corporate Governance Stock Information Investor Events Investor News Financial Information Quarterly Updates Annual Reports SEC Filings Analysts Investor Resources Investor Kit E-mail Alerts FAQs IR Contact News & Events In the News Awards Press Releases Social Media Careers Working at Acorda Our Employees Benefits Job Openings Application Privacy Policy Terms Of Use Site Map Contact Us Latest Latest News August 4, 2020 Acorda Reports Second Quarter 2020 Financial Results Read More July 31, 2020 Acorda Therapeutics Announces Adjournment of Special Meeting of Stockholders Read More View News Archives Pipeline Acorda is dedicated to the development and commercialization of novel therapies that restore function and improve the lives of people with a range of nervous system disorders. Development on the pipeline is currently deferred. LEARN MORE Click on a product below to learn more PLUMIAZ TM -- CVT-301 -- TOZADENANT (SYN115) -- SYN120 -- BTT1023 (timolumab) SYN120 Cimaglermin alfa (GGF2) rHlgM22 DALFAMPRIDINE -- CIMAGLERMIN ALFA AC105 CHONDROITINASE AMPYRA ® ZANAFLEX ® QUTENZA ® -- Latest Latest Events August 4, 2020 Acorda Provides Financial and Business Update for Second Quarter 2020 Listen to webcast View Press Release ( ) Read More May 5, 2020 Acorda Provides Financial and Business Update for First Quarter 2020 Listen to webcast View Press Release ( ) Read More View More Events Quick Links View our investor kit MEET OUR LEADERSHIP TEAM Board Of Directors Contact Us Pipeline SEC Filings Email Alerts Un-subscribe from email alerts Email Address * Mailing Lists * News Releases Alert SEC Alert Events Alert Calendar Alert Text size Normal Larger Largest Print -- ABOUT ACORDA Company Leadership Management Team Board of Directors Partnering With Acorda Grant Program Scientific Award Compliance Acorda Compliance Biotie EFPIA Discolsures Message From BIO Diversity and Inclusion Contact Us FOR PATIENTS Focus On Therapies In The Community Resources Policy on Access to Unapproved or Uncommericalized Medicines PRODUCTS & RESEARCH Pipeline ARCUS® Technology Products AMPYRA® (dalfampridine) INBRIJA™ (levodopa inhalation powder) Terms and Conditions (Product Purchases) Clinical Trials INVESTORS Corporate Governance Stock Information Investors Events Investor News Financial Information Quarterly Reports Annual Reports SEC Filings Analysts Investor Resources Investor Kit E-mail Alerts FAQs IR Contact NEWS & EVENTS In The News Awards Investor News Social Media CAREERS Working At Acorda Our Employees Benefits Job Openings Application Home | Privacy Policy | Terms Of Use | Site Map | Contact Us © Copyright 2017 Powered By Q4 Inc. 5.44.0.2...
ir.acorda.com Whois
"domain_name": "ACORDA.COM",
"registrar": "Network Solutions, LLC",
"whois_server": "whois.networksolutions.com",
"referral_url": null,
"updated_date": [
"2019-05-28 07:00:46",
"2019-05-28 07:01:19"
],
"creation_date": "1997-07-28 04:00:00",
"expiration_date": "2024-07-27 04:00:00",
"name_servers": [
"DNS1.CV.NET",
"DNS1.CVNET.COM"
],
"status": "clientTransferProhibited https://icann.org/epp#clientTransferProhibited",
"emails": [
"abuse@web.com",
"domains@acorda.digital",
"eruiz@acorda.com",
"rm-hostmaster@ems.att.com"
],
"dnssec": "unsigned",
"name": "Acorda Therapeutics, Inc",
"org": "Acorda Therapeutics, Inc",
"address": "420 SAW MILL RIVER RD",
"city": "ARDSLEY",
"state": "NY",
"zipcode": "10502-2605",
"country": "US"